Additional protein and peptide toxins from Agkistrodon acutus venom

Additional protein and peptide toxins from Agkistrodon acutus venom refers to the heterogeneous collection of bioactive molecules found in the venom of the sharp-nosed pit viper, scientifically known as Deinagkistrodon acutus (UniProt Knowledgebase, 2024). This venom is characterized by its potent hemotoxic and cytotoxic effects, mediated by a variety of enzymes including snake venom metalloproteinases (SVMPs), serine proteases, and phospholipases A2, as well as non-enzymatic proteins like disintegrins and C-type lectins (Therapeutic Target Database, 2024). These components act synergistically to disrupt the host's hemostatic system, leading to severe internal bleeding, consumption coagulopathy, and extensive local tissue destruction. While these toxins are the primary cause of morbidity and mortality in snakebite victims, they also serve as critical targets for antivenom therapy and provide a rich source of lead compounds for developing anticoagulants and anti-cancer agents. The classification of these toxins as a single target is generally considered incorrect in a strict pharmacological sense because it encompasses multiple distinct protein families with divergent mechanisms of action (PubMed: 26456018).

Other names

Deinagkistrodon acutus venom toxinsSharp-nosed pit viper venom proteinsFive-pacer viper venom componentsAgkistrodon acutus venom proteins

The primary therapeutic mechanism involves the administration of specific antivenoms containing polyclonal antibodies that bind to and neutralize the various toxic proteins and peptides in the venom (PubMed: 15621213). Experimental small-molecule inhibitors like varespladib target the enzymatic activity of phospholipase A2 (PLA2), while metalloproteinase inhibitors like batimastat aim to prevent the degradation of the extracellular matrix and subsequent hemorrhage (Journal of Venomous Animals and Toxins including Tropical Diseases, 2018).